This site is intended for healthcare professionals only
LoginRegister
Over 9,000 Serious Adverse Events Reported in India Clinical Trials in 5 Years: Govt DataOver 9,000 Serious Adverse Events Reported in India Clinical Trials in 5 Years: Govt Data
Mankind Pharma Acquires Rivotril Brand from Roche to Boost CNS Portfolio in IndiaMankind Pharma Acquires Rivotril Brand from Roche to Boost CNS Portfolio in India
AurobindoAurobindo Pharma Gets 3 USFDA Observations for Apitoria Unit-V, Classified as VAI
Alkem to Invest Rs 533 Crore in New Formulations Plant in Ujjain, Secures 30-Acre LandAlkem to Invest Rs 533 Crore in New Formulations Plant in Ujjain, Secures 30-Acre Land
GSK Gets USFDA Nod for Liver Disease-Related Itching Drug LynavoyGSK Gets USFDA Nod for Liver Disease-Related Itching Drug Lynavoy
Semaglutide Patent Expiry Sparks Generic Rush in India, Prices Set to Drop SharplySemaglutide Patent Expiry Sparks Generic Rush in India, Prices Set to Drop Sharply
Alleged Inaction Over Ozempic Misuse for Weight Loss, Delhi HC Seeks Govt, CDSCO ResponseAlleged Inaction Over Ozempic Misuse for Weight Loss, Delhi HC Seeks Govt, CDSCO Response
Dr ReddyDr Reddy's Slapped Rs 2.19 Crore GST Demand for FY20-22, Plans to Challenge Orders
USFDA Flags Aurobindos Eugia Unit-II with OAI Status After Bhiwadi InspectionUSFDA Flags Aurobindo's Eugia Unit-II with OAI Status After Bhiwadi Inspection
Fake Drug Inspector Arrested in Jaipur for Extorting Chemists, Running Job ScamFake Drug Inspector Arrested in Jaipur for Extorting Chemists, Running Job Scam
Johnson and Johnson Gets USFDA Nod for Oral Psoriasis Drug IcotydeJohnson and Johnson Gets USFDA Nod for Oral Psoriasis Drug Icotyde
USFDA Pushes Shift from Animal Testing, Draft Guidance Backs AI and Human-Based Drug ResearchUSFDA Pushes Shift from Animal Testing, Draft Guidance Backs AI and Human-Based Drug Research
X